 Laura Brown
Concepts (245)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fetal Growth Retardation | 30 | 2023 | 467 | 7.190 |
Why?
| | Fetus | 33 | 2023 | 699 | 5.450 |
Why?
| | Amino Acids | 21 | 2023 | 448 | 5.430 |
Why?
| | Placental Insufficiency | 15 | 2023 | 102 | 5.270 |
Why?
| | Sheep | 47 | 2023 | 764 | 4.440 |
Why?
| | Muscle, Skeletal | 17 | 2022 | 1472 | 3.630 |
Why?
| | Fetal Development | 11 | 2021 | 246 | 2.970 |
Why?
| | Glucose | 23 | 2023 | 896 | 2.720 |
Why?
| | Insulin | 29 | 2023 | 2076 | 2.160 |
Why?
| | Pregnancy | 54 | 2023 | 5516 | 2.060 |
Why?
| | Leucine | 10 | 2022 | 102 | 1.870 |
Why?
| | Myoblasts | 3 | 2021 | 76 | 1.770 |
Why?
| | Infant, Premature | 6 | 2023 | 476 | 1.350 |
Why?
| | Dietary Proteins | 3 | 2023 | 122 | 1.270 |
Why?
| | Enteral Nutrition | 2 | 2023 | 159 | 1.220 |
Why?
| | Liver | 13 | 2021 | 1633 | 1.180 |
Why?
| | Hyperinsulinism | 6 | 2020 | 103 | 1.120 |
Why?
| | Insulin-Like Growth Factor I | 4 | 2023 | 286 | 1.110 |
Why?
| | Infant Nutritional Physiological Phenomena | 5 | 2023 | 133 | 1.100 |
Why?
| | Animals | 56 | 2023 | 31692 | 1.080 |
Why?
| | Muscle Development | 3 | 2021 | 98 | 1.020 |
Why?
| | Muscle Fibers, Skeletal | 3 | 2021 | 185 | 0.990 |
Why?
| | Fetal Weight | 3 | 2022 | 52 | 0.970 |
Why?
| | Hindlimb | 3 | 2021 | 130 | 0.900 |
Why?
| | Cell Proliferation | 3 | 2021 | 2186 | 0.880 |
Why?
| | Hypoxia | 5 | 2021 | 956 | 0.860 |
Why?
| | Muscle Proteins | 3 | 2022 | 210 | 0.850 |
Why?
| | Parenteral Nutrition | 1 | 2023 | 96 | 0.840 |
Why?
| | Placenta | 8 | 2023 | 625 | 0.830 |
Why?
| | Infant Formula | 3 | 2014 | 74 | 0.820 |
Why?
| | Female | 59 | 2023 | 59446 | 0.820 |
Why?
| | Infant, Extremely Premature | 1 | 2023 | 57 | 0.820 |
Why?
| | Infant, Newborn | 10 | 2023 | 5040 | 0.790 |
Why?
| | Pancreas | 6 | 2021 | 276 | 0.790 |
Why?
| | Myoblasts, Skeletal | 1 | 2021 | 11 | 0.780 |
Why?
| | Citrate (si)-Synthase | 1 | 2021 | 46 | 0.780 |
Why?
| | Gestational Age | 11 | 2023 | 759 | 0.760 |
Why?
| | Hypoglycemia | 6 | 2015 | 386 | 0.670 |
Why?
| | Protein Biosynthesis | 3 | 2017 | 385 | 0.660 |
Why?
| | Maternal-Fetal Exchange | 6 | 2021 | 151 | 0.640 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2023 | 1213 | 0.640 |
Why?
| | Fetal Heart | 1 | 2018 | 37 | 0.620 |
Why?
| | Oxidation-Reduction | 8 | 2021 | 923 | 0.610 |
Why?
| | Ibuprofen | 1 | 2018 | 75 | 0.590 |
Why?
| | Ductus Arteriosus, Patent | 1 | 2018 | 50 | 0.590 |
Why?
| | Gluconeogenesis | 6 | 2019 | 62 | 0.550 |
Why?
| | Mitochondria | 1 | 2021 | 747 | 0.530 |
Why?
| | Lower Extremity | 1 | 2019 | 335 | 0.520 |
Why?
| | Sweetening Agents | 1 | 2015 | 37 | 0.510 |
Why?
| | Oxidative Stress | 1 | 2021 | 1076 | 0.510 |
Why?
| | Infusions, Intravenous | 5 | 2021 | 371 | 0.500 |
Why?
| | Lactic Acid | 7 | 2023 | 275 | 0.500 |
Why?
| | Cell Division | 1 | 2017 | 758 | 0.490 |
Why?
| | Islets of Langerhans | 5 | 2021 | 726 | 0.480 |
Why?
| | Hypoglycemic Agents | 2 | 2021 | 1008 | 0.480 |
Why?
| | Myocytes, Cardiac | 1 | 2018 | 449 | 0.470 |
Why?
| | Milk, Human | 2 | 2020 | 127 | 0.460 |
Why?
| | Endocrine System | 1 | 2014 | 19 | 0.460 |
Why?
| | Fetal Hypoxia | 3 | 2021 | 47 | 0.450 |
Why?
| | Growth | 1 | 2013 | 55 | 0.440 |
Why?
| | Developmental Disabilities | 1 | 2015 | 237 | 0.420 |
Why?
| | Disease Models, Animal | 8 | 2021 | 3531 | 0.420 |
Why?
| | Dietary Supplements | 3 | 2012 | 460 | 0.420 |
Why?
| | Dietary Carbohydrates | 2 | 2014 | 138 | 0.420 |
Why?
| | Intelligence | 1 | 2013 | 130 | 0.420 |
Why?
| | Organ Size | 5 | 2021 | 434 | 0.400 |
Why?
| | Placental Circulation | 2 | 2021 | 56 | 0.380 |
Why?
| | Prenatal Exposure Delayed Effects | 2 | 2014 | 452 | 0.370 |
Why?
| | Weight Gain | 1 | 2013 | 453 | 0.350 |
Why?
| | Fetal Blood | 6 | 2021 | 270 | 0.350 |
Why?
| | Blood Glucose | 10 | 2019 | 1819 | 0.350 |
Why?
| | Glucose Clamp Technique | 4 | 2020 | 181 | 0.350 |
Why?
| | Mannose | 1 | 2009 | 21 | 0.330 |
Why?
| | Inositol | 1 | 2009 | 23 | 0.330 |
Why?
| | Body Weight | 1 | 2013 | 868 | 0.330 |
Why?
| | Energy Metabolism | 3 | 2021 | 731 | 0.320 |
Why?
| | Sugar Alcohols | 1 | 2008 | 3 | 0.320 |
Why?
| | Carbohydrates | 1 | 2008 | 55 | 0.310 |
Why?
| | Postprandial Period | 1 | 2008 | 87 | 0.300 |
Why?
| | Milk | 1 | 2008 | 124 | 0.290 |
Why?
| | Random Allocation | 5 | 2012 | 335 | 0.290 |
Why?
| | Drug Administration Schedule | 4 | 2021 | 718 | 0.290 |
Why?
| | Oxygen | 6 | 2023 | 854 | 0.280 |
Why?
| | Proteins | 1 | 2012 | 908 | 0.270 |
Why?
| | Glucagon | 5 | 2021 | 92 | 0.250 |
Why?
| | Up-Regulation | 4 | 2017 | 807 | 0.240 |
Why?
| | Humans | 20 | 2023 | 114599 | 0.230 |
Why?
| | Infant, Small for Gestational Age | 2 | 2022 | 76 | 0.230 |
Why?
| | Adaptation, Physiological | 2 | 2021 | 483 | 0.220 |
Why?
| | Ultrasonography, Prenatal | 2 | 2022 | 235 | 0.220 |
Why?
| | Amines | 1 | 2023 | 34 | 0.210 |
Why?
| | Blotting, Western | 4 | 2019 | 1147 | 0.200 |
Why?
| | Cystathionine gamma-Lyase | 1 | 2020 | 11 | 0.180 |
Why?
| | Oxidative Phosphorylation | 1 | 2021 | 155 | 0.180 |
Why?
| | Placentation | 1 | 2021 | 40 | 0.180 |
Why?
| | Dairy Products | 1 | 2021 | 30 | 0.180 |
Why?
| | Hydrogen Sulfide | 1 | 2020 | 40 | 0.180 |
Why?
| | Phosphoenolpyruvate Carboxykinase (ATP) | 2 | 2012 | 15 | 0.180 |
Why?
| | Insulin Resistance | 4 | 2019 | 1072 | 0.170 |
Why?
| | Adipose Tissue | 2 | 2021 | 539 | 0.170 |
Why?
| | Meat | 1 | 2021 | 87 | 0.170 |
Why?
| | Insulin-Secreting Cells | 3 | 2012 | 317 | 0.170 |
Why?
| | Body Composition | 2 | 2022 | 590 | 0.170 |
Why?
| | Metformin | 1 | 2023 | 276 | 0.170 |
Why?
| | Bromodeoxyuridine | 1 | 2019 | 72 | 0.170 |
Why?
| | Amino Acid Transport Systems | 1 | 2020 | 38 | 0.170 |
Why?
| | Pregnancy, Animal | 1 | 2019 | 52 | 0.170 |
Why?
| | Blood Gas Analysis | 2 | 2012 | 72 | 0.170 |
Why?
| | Alanine | 1 | 2019 | 104 | 0.160 |
Why?
| | Point-of-Care Systems | 1 | 2020 | 136 | 0.160 |
Why?
| | Adenosine Triphosphatases | 1 | 2020 | 153 | 0.160 |
Why?
| | Sodium | 1 | 2020 | 183 | 0.160 |
Why?
| | Gynecology | 1 | 2021 | 163 | 0.160 |
Why?
| | Amino Acids, Branched-Chain | 4 | 2021 | 31 | 0.160 |
Why?
| | RNA, Messenger | 4 | 2016 | 2552 | 0.150 |
Why?
| | Male | 9 | 2021 | 55534 | 0.150 |
Why?
| | Phosphoenolpyruvate Carboxykinase (GTP) | 2 | 2016 | 32 | 0.150 |
Why?
| | Indomethacin | 1 | 2018 | 70 | 0.150 |
Why?
| | Glucose-6-Phosphatase | 3 | 2016 | 31 | 0.150 |
Why?
| | Anemia | 2 | 2017 | 143 | 0.150 |
Why?
| | Hepatocytes | 4 | 2023 | 195 | 0.150 |
Why?
| | Temperature | 1 | 2019 | 565 | 0.140 |
Why?
| | Protein Kinases | 2 | 2009 | 307 | 0.140 |
Why?
| | Infant | 4 | 2023 | 7954 | 0.140 |
Why?
| | Metabolomics | 1 | 2021 | 521 | 0.130 |
Why?
| | Kinetics | 2 | 2012 | 1551 | 0.130 |
Why?
| | Infusion Pumps | 2 | 2021 | 31 | 0.130 |
Why?
| | Acetaminophen | 1 | 2018 | 238 | 0.130 |
Why?
| | Breast Feeding | 2 | 2009 | 368 | 0.130 |
Why?
| | Lactates | 1 | 2015 | 79 | 0.130 |
Why?
| | Gene Expression Regulation | 4 | 2020 | 2319 | 0.120 |
Why?
| | Endocrine System Diseases | 1 | 2014 | 30 | 0.120 |
Why?
| | Pregnancy Complications | 1 | 2019 | 429 | 0.120 |
Why?
| | In Vitro Techniques | 1 | 2016 | 1016 | 0.110 |
Why?
| | Hydrops Fetalis | 1 | 2014 | 13 | 0.110 |
Why?
| | Nutritional Requirements | 1 | 2014 | 75 | 0.110 |
Why?
| | Time Factors | 4 | 2012 | 6112 | 0.110 |
Why?
| | Diet | 1 | 2021 | 1080 | 0.110 |
Why?
| | Hemangioma | 1 | 2014 | 41 | 0.110 |
Why?
| | Algorithms | 3 | 2014 | 1466 | 0.110 |
Why?
| | Arginine | 2 | 2012 | 237 | 0.110 |
Why?
| | Carbon Dioxide | 2 | 2012 | 218 | 0.110 |
Why?
| | Food | 1 | 2014 | 160 | 0.100 |
Why?
| | Signal Transduction | 5 | 2020 | 4509 | 0.100 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2017 | 1842 | 0.100 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2014 | 141 | 0.100 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2014 | 351 | 0.100 |
Why?
| | Acid-Base Equilibrium | 1 | 2012 | 29 | 0.100 |
Why?
| | Heart | 1 | 2016 | 612 | 0.100 |
Why?
| | AMP-Activated Protein Kinases | 2 | 2023 | 172 | 0.100 |
Why?
| | Malnutrition | 1 | 2012 | 62 | 0.100 |
Why?
| | Pulmonary Gas Exchange | 1 | 2012 | 117 | 0.100 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2014 | 176 | 0.100 |
Why?
| | Carbon Isotopes | 1 | 2012 | 111 | 0.100 |
Why?
| | Sheep, Domestic | 3 | 2019 | 33 | 0.100 |
Why?
| | Proteolysis | 1 | 2012 | 142 | 0.100 |
Why?
| | Tissue Distribution | 1 | 2012 | 286 | 0.100 |
Why?
| | Hormones | 1 | 2012 | 132 | 0.090 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2012 | 313 | 0.090 |
Why?
| | Apoptosis | 1 | 2019 | 2362 | 0.090 |
Why?
| | Prospective Studies | 1 | 2022 | 6214 | 0.090 |
Why?
| | Taurine | 1 | 2011 | 41 | 0.090 |
Why?
| | TOR Serine-Threonine Kinases | 2 | 2009 | 358 | 0.080 |
Why?
| | Ribosomal Protein S6 Kinases | 1 | 2008 | 21 | 0.080 |
Why?
| | Eukaryotic Initiation Factor-4E | 1 | 2008 | 27 | 0.080 |
Why?
| | Glycine | 2 | 2023 | 152 | 0.080 |
Why?
| | Somatostatin | 1 | 2008 | 52 | 0.080 |
Why?
| | Galactose | 1 | 2008 | 20 | 0.080 |
Why?
| | Hydrocortisone | 3 | 2016 | 267 | 0.080 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2008 | 146 | 0.080 |
Why?
| | Acidosis | 1 | 2009 | 88 | 0.070 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2007 | 127 | 0.070 |
Why?
| | Lysine | 1 | 2009 | 242 | 0.070 |
Why?
| | Lipid Metabolism | 2 | 2020 | 444 | 0.070 |
Why?
| | Down-Regulation | 3 | 2017 | 594 | 0.070 |
Why?
| | Fetal Diseases | 2 | 2021 | 147 | 0.060 |
Why?
| | Embryo, Mammalian | 2 | 2019 | 213 | 0.060 |
Why?
| | Pyruvates | 1 | 2023 | 20 | 0.050 |
Why?
| | Glutamine | 1 | 2023 | 91 | 0.050 |
Why?
| | Serine | 1 | 2023 | 126 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2019 | 923 | 0.050 |
Why?
| | Mammals | 1 | 2023 | 244 | 0.050 |
Why?
| | Pyruvic Acid | 1 | 2021 | 42 | 0.050 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2019 | 800 | 0.050 |
Why?
| | Isoleucine | 1 | 2021 | 11 | 0.050 |
Why?
| | Amino Acids, Essential | 1 | 2021 | 12 | 0.050 |
Why?
| | Fetal Macrosomia | 1 | 2021 | 58 | 0.050 |
Why?
| | Phenylalanine | 1 | 2021 | 57 | 0.050 |
Why?
| | Pancreatic Diseases | 1 | 2021 | 64 | 0.050 |
Why?
| | Carnitine | 1 | 2021 | 62 | 0.050 |
Why?
| | Valine | 1 | 2021 | 72 | 0.040 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2011 | 2094 | 0.040 |
Why?
| | Mitochondria, Liver | 1 | 2020 | 67 | 0.040 |
Why?
| | Glycolysis | 1 | 2021 | 226 | 0.040 |
Why?
| | Uterine Artery | 1 | 2020 | 67 | 0.040 |
Why?
| | Drug Synergism | 1 | 2020 | 316 | 0.040 |
Why?
| | Transcription Factors | 1 | 2007 | 1527 | 0.040 |
Why?
| | Glutathione | 1 | 2020 | 293 | 0.040 |
Why?
| | Proton Magnetic Resonance Spectroscopy | 1 | 2019 | 20 | 0.040 |
Why?
| | Birth Weight | 1 | 2021 | 440 | 0.040 |
Why?
| | Estrogens | 1 | 2020 | 312 | 0.040 |
Why?
| | Oxygen Consumption | 1 | 2020 | 588 | 0.040 |
Why?
| | Chronic Disease | 2 | 2017 | 1578 | 0.040 |
Why?
| | Homeostasis | 1 | 2020 | 573 | 0.040 |
Why?
| | Diabetes, Gestational | 1 | 2021 | 281 | 0.040 |
Why?
| | Glycogen | 1 | 2016 | 51 | 0.030 |
Why?
| | Umbilical Cord | 1 | 2016 | 80 | 0.030 |
Why?
| | Carbon Radioisotopes | 1 | 2014 | 36 | 0.030 |
Why?
| | Models, Animal | 1 | 2016 | 344 | 0.030 |
Why?
| | Biological Transport | 1 | 2014 | 373 | 0.030 |
Why?
| | Transcriptome | 1 | 2019 | 724 | 0.030 |
Why?
| | Blood Transfusion | 1 | 2016 | 293 | 0.030 |
Why?
| | Animals, Inbred Strains | 1 | 2012 | 7 | 0.030 |
Why?
| | Glutamic Acid | 1 | 2014 | 211 | 0.030 |
Why?
| | Fatal Outcome | 1 | 2014 | 284 | 0.030 |
Why?
| | Electrolytes | 1 | 2012 | 55 | 0.030 |
Why?
| | Cell Size | 1 | 2012 | 80 | 0.030 |
Why?
| | Glucagon-Secreting Cells | 1 | 2012 | 20 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2019 | 1518 | 0.030 |
Why?
| | Solutions | 1 | 2012 | 146 | 0.030 |
Why?
| | Prenatal Diagnosis | 1 | 2014 | 167 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2021 | 4411 | 0.030 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2012 | 144 | 0.020 |
Why?
| | Forkhead Transcription Factors | 1 | 2012 | 170 | 0.020 |
Why?
| | Energy Intake | 1 | 2014 | 427 | 0.020 |
Why?
| | Erythrocytes | 1 | 2016 | 591 | 0.020 |
Why?
| | Myocardium | 1 | 2016 | 913 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2012 | 398 | 0.020 |
Why?
| | Adenylate Kinase | 1 | 2009 | 26 | 0.020 |
Why?
| | Peptide Chain Initiation, Translational | 1 | 2009 | 38 | 0.020 |
Why?
| | Infusions, Parenteral | 1 | 2009 | 36 | 0.020 |
Why?
| | Biomarkers | 1 | 2019 | 3405 | 0.020 |
Why?
| | Remission Induction | 1 | 2009 | 233 | 0.020 |
Why?
| | Fever | 1 | 2009 | 280 | 0.020 |
Why?
| | Liver Glycogen | 1 | 2007 | 17 | 0.020 |
Why?
| | Oncogene Protein v-akt | 1 | 2007 | 26 | 0.020 |
Why?
| | Receptor, Insulin | 1 | 2007 | 93 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2009 | 511 | 0.020 |
Why?
| | Cloning, Molecular | 1 | 2007 | 522 | 0.020 |
Why?
| | Mice | 1 | 2020 | 14859 | 0.010 |
Why?
| | Phosphorylation | 1 | 2007 | 1569 | 0.010 |
Why?
| | Models, Biological | 1 | 2009 | 1620 | 0.010 |
Why?
| | Obesity | 1 | 2011 | 2507 | 0.010 |
Why?
| | Adolescent | 1 | 2014 | 17827 | 0.010 |
Why?
| | Adult | 1 | 2011 | 30514 | 0.010 |
Why?
|
|
Brown's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|